Hjem › Blodlidelser › New York
Kliniske studier for Blodlidelser i New York
12 studier for Blodlidelser søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens Hospital at Montefiore, The Bronx
RekruttererFase 3
Alder 12 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06439082Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 4, Buffalo
- Quetzal Site 2, The Bronx
RekruttererFase 3
Alder 18 til 71 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07504458A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06722235A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- NY Cancer and Blood Specialists, Shirley
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06948318ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- og 2 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07216443A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Roswell Park Comprehensive Cancer Center, Buffalo
- New York University Langone Hospital - Long Island, Mineola
- Perlmutter Cancer Center - 34th Street, New York
- og 2 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. apr. 2026 · NCT04256317Diamond Blackfan Anemia Registry (DBAR)
- Cohen Children's Medical Center of NY, New Hyde Park
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT00106015Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
RekruttererFase 3
Alder 12 til 35 · Alle kjønn · Oppdatert 23. mar. 2026 · NCT05477563Hematology Biobank: In Vitro Study of Blood Disorders
- Montefiore Medical Center, The Bronx
RekruttererObservasjonsstudie
Alder 12 og eldre · Alle kjønn · Oppdatert 6. jan. 2026 · NCT02442011Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
- Columbia University, New York
- Montefiore Einstein Cancer Center, The Bronx
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2025 · NCT05423691Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.